There are 2949 resources available
160O - Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer, TNBC) (PM(Cb)) for patients (pts) with high-risk early breast cancer (BC)
Presenter: Andreas Schneeweiss
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA12 - PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer
Presenter: Erica Mayer
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
161O - Randomized preoperative window of opportunity (WOO) study with the CDK4/6 inhibitor abemaciclib in early breast cancer (EBC) patients and differential gene expression pathway analyses with palbociclib
Presenter: Monica Arnedos
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
CN34 - Management of immunotherapy toxicities: A new challenge
Presenter: Laura Bascuñana Sanchez
Session: EONS13: Immunotherapy and precision oncology: What do patients need?
Resources:
Abstract
Slides
Webcast
Why do we need phase I clinical trials?
Presenter: Martijn Lolkema
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Slides
Webcast
From referral for to participation in phase I clinical trials: Patient journeys and preliminary results in the development of an online value clarification tool
Presenter: Liza Van Lent
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Ruben Martin Payo
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Webcast
Invited Discussant 1257O and 1258O
Presenter: Colin Lindsay
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lecia Sequist
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Webcast
Invited Discussant LBA50 and 1259O
Presenter: Lecia Sequist
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Webcast